Loading clinical trials...
Loading clinical trials...
This study is a retrospective study trying to find the predictive factors for medullary thyroid aggressiveness in terms of tumor metastasis and patients' survival.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Aristotle University Of Thessaloniki
NCT06814496 · Melanoma, Medullary Thyroid Cancer, and more
NCT01109420 · Non-Medullary Thyroid Cancer
NCT01660984 · Medullary Thyroid Cancer
NCT06523582 · Neuroendocrine Neoplasm, Neuroendocrine Neoplasm of Gastrointestinal Tract, and more
NCT03157128 · Non-Small Cell Lung Cancer, Medullary Thyroid Cancer, and more
Oregon Health & Science University, Oregon
Oregon City, Oregon
Department of Surgery, Saint John of God Hospital, Salzburg, Austria
Salzburg
Saint Luc, University Clouvain, Belgium
Brussels
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions